Strong Buy
Average AnalystStrong Buy
Top AnalystSlightly Bearish
Stock Target AdvisorN/A
Average UserUSD 20.37
+1.20 (+6.26)%
USD 1.31B
0.81M
USD 30.29(+48.68%)
Symbol | Name | Exchange | SDGR's Weight | Expense Ratio | Price(Change) | Market Cap |
---|---|---|---|---|---|---|
|
ARK Genomic Revolution UC.. | LSE | 4.10 % | 0.00 % | +0.78 (+0.23%) | USD3.69M |
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company had positive total cash flow in the most recent four quarters.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
The stock is trading high compared to its peers median on a price to book value basis.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The company had negative total free cash flow in the most recent four quarters.